IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,569,898 | +12.5% | 2,194,731 | +1.8% | 0.01% | +20.0% |
| Q2 2023 | $88,496,334 | +19.6% | 2,156,868 | +4.2% | 0.01% | 0.0% |
| Q1 2023 | $73,980,050 | +97216.6% | 2,069,950 | +2.8% | 0.01% | -9.1% |
| Q4 2022 | $76,020 | -99.9% | 2,012,723 | +5.9% | 0.01% | -15.4% |
| Q3 2022 | $84,087,000 | +21.8% | 1,901,143 | +1.9% | 0.01% | +30.0% |
| Q2 2022 | $69,047,000 | -1.8% | 1,865,133 | -1.7% | 0.01% | +11.1% |
| Q1 2022 | $70,283,000 | +26.5% | 1,897,492 | +4.0% | 0.01% | +28.6% |
| Q4 2021 | $55,541,000 | -6.6% | 1,825,226 | +3.0% | 0.01% | -12.5% |
| Q3 2021 | $59,458,000 | -15.4% | 1,772,767 | +0.6% | 0.01% | -20.0% |
| Q2 2021 | $70,307,000 | -9.5% | 1,762,540 | +1.9% | 0.01% | -16.7% |
| Q1 2021 | $77,645,000 | -17.8% | 1,729,146 | +3.4% | 0.01% | -25.0% |
| Q4 2020 | $94,429,000 | +25.2% | 1,672,204 | +5.2% | 0.02% | +6.7% |
| Q3 2020 | $75,394,000 | -16.6% | 1,590,294 | +3.7% | 0.02% | -21.1% |
| Q2 2020 | $90,357,000 | +28.3% | 1,533,785 | +2.9% | 0.02% | +5.6% |
| Q1 2020 | $70,439,000 | -59.6% | 1,491,065 | -48.4% | 0.02% | 0.0% |
| Q4 2019 | $174,268,000 | +103.8% | 2,887,484 | +102.2% | 0.02% | -10.0% |
| Q3 2019 | $85,494,000 | -14.8% | 1,428,037 | -8.6% | 0.02% | -16.7% |
| Q2 2019 | $100,327,000 | -12.8% | 1,561,997 | +10.2% | 0.02% | -20.0% |
| Q1 2019 | $115,011,000 | -20.7% | 1,416,922 | -47.2% | 0.03% | +36.4% |
| Q4 2018 | $145,034,000 | +123.3% | 2,682,866 | +113.0% | 0.02% | +22.2% |
| Q3 2018 | $64,953,000 | +35.0% | 1,259,281 | +9.1% | 0.02% | +20.0% |
| Q2 2018 | $48,119,000 | -0.1% | 1,154,765 | +5.6% | 0.02% | -6.2% |
| Q1 2018 | $48,181,000 | -10.8% | 1,093,042 | +1.8% | 0.02% | -11.1% |
| Q4 2017 | $54,028,000 | +1.5% | 1,074,130 | +2.3% | 0.02% | -10.0% |
| Q3 2017 | $53,216,000 | +1.8% | 1,049,631 | +2.2% | 0.02% | -4.8% |
| Q2 2017 | $52,253,000 | +37.1% | 1,027,200 | +8.4% | 0.02% | +31.2% |
| Q1 2017 | $38,105,000 | -8.7% | 947,906 | +8.6% | 0.02% | -15.8% |
| Q4 2016 | $41,749,000 | +39.3% | 872,879 | +6.7% | 0.02% | +26.7% |
| Q3 2016 | $29,976,000 | +62.3% | 818,128 | +3.1% | 0.02% | +50.0% |
| Q2 2016 | $18,475,000 | -40.0% | 793,668 | +4.3% | 0.01% | -37.5% |
| Q1 2016 | $30,802,000 | -31.7% | 760,951 | +4.4% | 0.02% | -38.5% |
| Q4 2015 | $45,117,000 | – | 728,970 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |